Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05218447 · ClinicalTrials.gov registry record · NA

Dosing of Overground Robotic Gait Training with Functional Outcomes and Neuroplasticity After Spinal Cord Injury

A NA study of Spinal Cord Injuries, sponsored by Baylor Research Institute.

Recruiting
Registry status
NA
Development phase
144
Enrollment target
1
Study location

NCT05218447: Recruiting NA study of Spinal Cord Injuries, sponsored by Baylor Research Institute.

NCT05218447 is a NA study of Spinal Cord Injuries that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 144 participants, above the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (136% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05218447, a NA study of Spinal Cord Injuries, is actively recruiting participants, sponsored by Baylor Research Institute.

RECRUITING
Registry status
NA
Development phase
144 participants
Enrollment target
1
Study location

Study Summary

The DOOR SCI project examines dosing effects of robotic gait training (RGT) and transcranial magnetic stimulation (TMS) initiated during inpatient rehabilitation and continued through early outpatient rehabilitation

Primary Outcome

The WISCI-II defines the physical limitation for gait secondary to impairment at the person level and indicates the ability of a person to walk after SCI. The WISC-II rank orders the ability a person to walk on a scale of 0-20 with 0 representing no ability to stand or participate in assisted walking and 20 representing an ability to walk 10 meters with no devices, no braces, and no physical assistance.

Conditions Studied

Interventions

  • DEVICE Robotic Gait Training
  • OTHER Usual Care (UC) Gait Training

Study Locations (1)

Texas

  • Baylor Scott & White Institute for Rehabilitation - Dallas

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2022-05-20
Est. Completion 2025-09-14
Phase NA
Baylor Research Institute

180 total trials

What NCT05218447 shows while recruiting

NCT05218447 is an interventional study that assigns participants to a tested intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, above the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (136% higher).

The record links to 1 condition, with Spinal Cord Injuries appearing as the primary indexed condition, and to 2 interventions - of which Robotic Gait Training is the first listed.

NCT05218447 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05218447 about?

NCT05218447 is a clinical study titled "Dosing of Overground Robotic Gait Training with Functional Outcomes and Neuroplasticity After Spinal Cord Injury". The DOOR SCI project examines dosing effects of robotic gait training (RGT) and transcranial magnetic stimulation (TMS) initiated during inpatient rehabilitation and continued through early outpatient rehabilitation

What is the current status of trial NCT05218447?

This trial is currently recruiting. It is a NA study. The enrollment target is 144 participants. The study started on 2022-05-20. Estimated completion is 2025-09-14.

What conditions does trial NCT05218447 study?

This clinical trial studies the following conditions: Spinal Cord Injuries.

What interventions are being tested in trial NCT05218447?

The interventions under investigation include: Robotic Gait Training (DEVICE), Usual Care (UC) Gait Training (OTHER).

Who is sponsoring clinical trial NCT05218447?

This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05218447 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05218447's enrollment target sits among peer trials

144 20th of 202 higher than 183 of 202 other Spinal Cord Injuries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01861106 · 144 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

  • NCT03482245 · 144 participants · NA

    The Role of Circadian Clock Proteins in Innate and Adaptive Immunity

  • NCT03504683 · 144 participants · NA

    MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes

  • NCT03905603 · 144 participants · Early Phase 1

    Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT05218447, the US trial registry maintained by the National Library of Medicine. NCT05218447 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.